Literature DB >> 24184555

Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.

Annie Park Moseman1, E Ashley Moseman, Stephen Schworer, Irina Smirnova, Tatyana Volkova, Ulrich von Andrian, Alexander Poltorak.   

Abstract

Recognition of microbial components is critical for activation of TLRs, subsequent innate immune signaling, and directing adaptive immune responses. The DNA sensor TLR9 traffics from the endoplasmic reticulum to endolysosomal compartments where it is cleaved by resident proteases to generate a competent receptor. Activation of TLR9 by CpG-motif containing oligodeoxynucleotides (CpG ODNs) is preceded by agonist endocytosis and delivery into the endolysosomes. The events that dictate this process remain largely unknown; furthermore, it is unclear whether the receptors involved in mediating uptake of exogenous DNA are conserved for both naturally derived pathogenic DNA and synthetic ODNs. In this study, we report that peritoneal macrophages from a wild-derived inbred mouse strain, MOLF/Ei, are hyporesponsive to CpG ODN but are fully responsive to bacterial DNA, thus implying that microbial recognition is not fully recapitulated by a synthetic analog. To identify the gene responsible for the CpG ODN defect, we have performed genome-wide linkage analysis. Using N2 backcross mice, we mapped the trait with high resolution to a single locus containing Mrc1 as the gene conferring the trait. We show that mannose receptor 1 (MRC1; CD206) is involved in CpG ODN uptake and trafficking in wild-derived MOLF/Ei peritoneal macrophages. Furthermore, we show that other strains of wild-derived mice also require MRC1 for CpG-induced cytokine responses. These findings reveal novel functions for MRC1 and demonstrate that wild-derived mice are important and indispensable model for understanding naturally occurring regulators of inflammatory responses in innate immune pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24184555      PMCID: PMC3834123          DOI: 10.4049/jimmunol.1301438

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  The mannose receptor: linking homeostasis and immunity through sugar recognition.

Authors:  Philip R Taylor; Siamon Gordon; Luisa Martinez-Pomares
Journal:  Trends Immunol       Date:  2005-02       Impact factor: 16.687

2.  Granulin is a soluble cofactor for toll-like receptor 9 signaling.

Authors:  Boyoun Park; Ludovico Buti; Sungwook Lee; Takashi Matsuwaki; Eric Spooner; Melanie M Brinkmann; Masugi Nishihara; Hidde L Ploegh
Journal:  Immunity       Date:  2011-04-14       Impact factor: 31.745

Review 3.  Structural requirements for uptake and recognition of CpG oligonucleotides.

Authors:  Klaus Heeg; Alexander Dalpke; Mirjam Peter; Stefan Zimmermann
Journal:  Int J Med Microbiol       Date:  2007-08-13       Impact factor: 3.473

4.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.

Authors:  Koichi Tabeta; Kasper Hoebe; Edith M Janssen; Xin Du; Philippe Georgel; Karine Crozat; Suzanne Mudd; Navjiwan Mann; Sosathya Sovath; Jason Goode; Louis Shamel; Anat A Herskovits; Daniel A Portnoy; Michael Cooke; Lisa M Tarantino; Tim Wiltshire; Benjamin E Steinberg; Sergio Grinstein; Bruce Beutler
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

5.  Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors.

Authors:  Michael K Mansour; Larry S Schlesinger; Stuart M Levitz
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides.

Authors:  Tara L Roberts; Jasmyn A Dunn; Tamsin D Terry; Michael P Jennings; David A Hume; Matthew J Sweet; Katryn J Stacey
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

7.  IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Authors:  Kenya Honda; Hideyuki Yanai; Hideo Negishi; Masataka Asagiri; Mitsuharu Sato; Tatsuaki Mizutani; Naoya Shimada; Yusuke Ohba; Akinori Takaoka; Nobuaki Yoshida; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-03-30       Impact factor: 49.962

8.  Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways.

Authors:  Kei Yasuda; Philipp Yu; Carsten J Kirschning; Beatrix Schlatter; Frank Schmitz; Antje Heit; Stefan Bauer; Hubertus Hochrein; Hermann Wagner
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

9.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

View more
  15 in total

1.  Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.

Authors:  Anna Karolina Kozlowska; Anna Florczak; Maciej Smialek; Ewelina Dondajewska; Andrzej Mackiewicz; Marcin Kortylewski; Hanna Dams-Kozlowska
Journal:  Acta Biomater       Date:  2017-07-08       Impact factor: 8.947

2.  Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics.

Authors:  Abul K Azad; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  J Cytol Mol Biol       Date:  2014-01-10

3.  RNA-Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators.

Authors:  Chenxia Guan; Natalia Chernyak; Donye Dominguez; Lisa Cole; Bin Zhang; Chad A Mirkin
Journal:  Small       Date:  2018-10-29       Impact factor: 13.281

4.  Toll-like receptor-mediated down-regulation of the deubiquitinase cylindromatosis (CYLD) protects macrophages from necroptosis in wild-derived mice.

Authors:  Stephen A Schworer; Irina I Smirnova; Irina Kurbatova; Uliana Bagina; Maria Churova; Trent Fowler; Ananda L Roy; Alexei Degterev; Alexander Poltorak
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

Review 5.  Wild-derived mice: from genetic diversity to variation in immune responses.

Authors:  Alexander Poltorak; Svetlana Apalko; Sergei Sherbak
Journal:  Mamm Genome       Date:  2018-07-28       Impact factor: 3.224

6.  CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity.

Authors:  Kosuke Tanegashima; Rena Takahashi; Hideko Nuriya; Rina Iwase; Naoto Naruse; Kohei Tsuji; Akira Shigenaga; Akira Otaka; Takahiko Hara
Journal:  EBioMedicine       Date:  2017-09-14       Impact factor: 8.143

7.  A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms.

Authors:  Ying-Chyi Song; Shih-Jen Liu
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

8.  High Endogenous Expression of Chitinase 3-Like 1 and Excessive Epithelial Proliferation with Colonic Tumor Formation in MOLF/EiJ Mice.

Authors:  Daren Low; Arianna K DeGruttola; Alexander Poltrak; Atsushi Mizoguchi; Mari Mino-Kenudson; Emiko Mizoguchi
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

9.  Reconstruction of Toll-like receptor 9-mediated responses in HEK-Blue hTLR9 cells by transfection of human macrophage scavenger receptor 1 gene.

Authors:  Shozo Ohtsuki; Yuki Takahashi; Takao Inoue; Yoshinobu Takakura; Makiya Nishikawa
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

10.  DCs facilitate B cell responses against microbial DNA via DC-SIGN.

Authors:  Joris K Sprokholt; Marieke H Heineke; Tanja M Kaptein; John L van Hamme; Teunis B H Geijtenbeek
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.